Krish W. Ramadurai

BranchLab is the AI platform for biopharma commercialization. Biopharma companies and their marketing agencies in-house BranchLab’s platform to model high-value patient and provider populations, activate omnichannel, and measure real-world outcomes without using personal health data. The BranchLab platform is designed to streamline how therapies are brought to market in the AI era

Recursive self-improving superintelligence to automate knowledge discovery.

Decode and design the interfaces of life

ALIGNMT AI enables healthcare organizations to confidently deploy advanced AI solutions by proactively addressing the core risks that hinder adoption: patient safety, data security, billing accuracy, and regulatory compliance. By operationalizing AI governance, we help health systems, payers, and life sciences companies unlock the full value of AI—safely, transparently, and at enterprise scale.

Meet Chromie, the future of hospital workforce automation. As seen in Forbes 30 Under 30, Chromie Health is revolutionizing hospital staffing and administration with AI-powered automation. Our platform seamlessly integrates with systems like ADT and Epic, replacing outdated manual processes with real-time, data-driven workforce management. Chromie generates optimal schedules in a single click, reducing nurse scheduling time by 8 hours per week and cutting annual staffing costs by $320K per unit. Chromie isn’t just another scheduling tool; it’s the first of many AI-driven solutions designed to transform hospital operations. By enhancing workforce efficiency, improving patient outcomes, and automating complex workflows, Chromie empowers hospitals to stay ahead of the growing demand for smarter, scalable solutions. With seamless 6-8 week integration, HIPAA-compliant AI that works with existing tech stacks, and proven success, Chromie Health is leading the charge in redefining healthcare workforce management, saving hospitals time, money, and lives.

A stealth mode biotech startup located in San Mateo county, CA.

WearLinq is a provider of digital healthcare solutions with a focus on ambulatory electrocardiogram (ECG) monitoring. The unique WearLinq system is designed to elevate the standard of remote cardiac monitoring by the enhanced detection of heart rhythm disorders and effectively reducing overall healthcare costs. The Wearlinq platform (or system) includes the first FDA cleared 6-lead cardiac monitor with multidimensional views of the heart for electrocardiogram (ECG) studies. Wearlinq is an Independent Diagnostic Testing Facility (“IDTF”) with clinical operations in Rockville, MD.

Developing the next generation of life-saving regenerative medicines with the worlds most advanced ML cell imaging platform.

Stealth AI Startup is a private community for founders, researchers, and engineers building next-generation AI companies before public launch. Founders tag themselves here to: 🔹 Gain credibility while working in stealth 🔹 Connect discreetly with other AI founders 🔹 Receive inbound interest from early-stage VCs 🔹 Join curated founder-only circles & discussions 🔹 Access hiring pipelines for early team building If youre building an AI startup in stealth, add your profile to the community and tag yourself to this page. Your stealth journey deserves visibility — without revealing your idea. Join the world’s largest AI stealth founder network.

A network for entrepreneurs building in stealth. Submit your information here so investors can find you: harmonic.ai/get-discovered

More than half of all clinical trials fail due to safety issues. Discovering drugs that show therapeutic potential is difficult, time-consuming, and expensive. But of those found, it is harder still to find those drugs which do not also have severe side effects and can pass through clinical trials. Most of these drugs are shelved and never reach patients. Safety issues are tough to fix without weakening the therapeutic effect, involving a mix of chemistry, biology, and knowledge of how humans will respond. Our proprietary AI model, SAFEPATH©, applies deep learning to our combined bioinformatics and cheminformatics datasets to solve drug safety issues. SAFEPATH© utilises the latest deep learning approaches to identify the mechanism of toxicity, predict its effects on the human body, and balance that with therapeutic effectiveness. We are building at speed a robust pipeline of matured assets. We look at historically failed clinical trials to identify the most promising targets as well as internal projects that were abandoned. By focusing on safety problems that occur in Preclinical, Phase 1, or Phase 2 trials, we are able to identify the most promising drugs therapeutically, turn them around quickly, and get them to patients faster than starting drug discovery from scratch. Our mission is to bring more treatments to patients, faster. Thousands of life-changing drugs fall at the last hurdle and never reach patients. We’re here to change that.

Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We are addressing previously unsolvable problems in cancer prognosis and treatment selection through cutting-edge foundation models and multi-modal data. Our first clinically validated offering, Ataraxis Breast, is the world’s first AI-native prognostic/predictive test for breast cancer and provides greater accuracy than standard of care genomic assays. To learn more, visit ataraxis.ai.

In stealth mode.

The Advanced Research Projects Agency for Health (ARPA-H) is committed to solving the most challenging problems in health by developing research programs dedicated to urgency, excellence and honesty. Part of the U.S. Department of Health and Human Services, ARPA-H aims to accelerate breakthroughs that empower every American to realize their full health potential – turning the seemingly impossible to the possible to the actual. The ARPA model is a continuous cycle of planning, implementing, and evaluating, and we’re looking for the best ideas and the brightest minds to carry out each process. Find more information about the agency and current job opportunities at https://arpa-h.gov

BranchLab is the AI platform for biopharma commercialization. Biopharma companies and their marketing agencies in-house BranchLab’s platform to model high-value patient and provider populations, activate omnichannel, and measure real-world outcomes without using personal health data. The BranchLab platform is designed to streamline how therapies are brought to market in the AI era

Recursive self-improving superintelligence to automate knowledge discovery.

Decode and design the interfaces of life

ALIGNMT AI enables healthcare organizations to confidently deploy advanced AI solutions by proactively addressing the core risks that hinder adoption: patient safety, data security, billing accuracy, and regulatory compliance. By operationalizing AI governance, we help health systems, payers, and life sciences companies unlock the full value of AI—safely, transparently, and at enterprise scale.

Meet Chromie, the future of hospital workforce automation. As seen in Forbes 30 Under 30, Chromie Health is revolutionizing hospital staffing and administration with AI-powered automation. Our platform seamlessly integrates with systems like ADT and Epic, replacing outdated manual processes with real-time, data-driven workforce management. Chromie generates optimal schedules in a single click, reducing nurse scheduling time by 8 hours per week and cutting annual staffing costs by $320K per unit. Chromie isn’t just another scheduling tool; it’s the first of many AI-driven solutions designed to transform hospital operations. By enhancing workforce efficiency, improving patient outcomes, and automating complex workflows, Chromie empowers hospitals to stay ahead of the growing demand for smarter, scalable solutions. With seamless 6-8 week integration, HIPAA-compliant AI that works with existing tech stacks, and proven success, Chromie Health is leading the charge in redefining healthcare workforce management, saving hospitals time, money, and lives.